Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart
- PMID: 11591623
- DOI: 10.1161/hc3901.095771
Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart
Abstract
Background: Induction of heat-shock proteins (HSPs) results in cardioprotection against ischemic insult. Geranylgeranylacetone (GGA), known as an antiulcer agent, reportedly induces HSP72 in the gastric mucosa and small intestine of rats. The present study tested the hypothesis that oral GGA would induce HSP72 in the heart and thus render cardioprotection against ischemia/reperfusion injury in rats.
Methods and results: Cardiac expression of HSPs was quantitatively evaluated in rats by Western blot analysis. Ten minutes of whole-body hyperthermia induced HSP72 expression in the rat hearts. A single oral dose of GGA (200 mg/kg) also induced expression of HSP72, which peaked at 24 hours after administration. Therefore, isolated perfused heart experiments using a Langendorff apparatus were performed 24 hours after administration of 200 mg/kg GGA (GGA group) or vehicle (control group). After a 5-minute stabilization period, no-flow global ischemia was given for 20, 40, or 60 minutes, followed by 30 minutes of reperfusion. During reperfusion, the functional recovery was greater and the released creatine kinase was less in the GGA group than in the control group. Electron microscopy findings revealed that the ischemia/reperfusion-induced damage of myocardial cells was prevented in GGA-treated myocytes.
Conclusions: The results suggest that oral GGA is cardioprotective against ischemic insult through its induction of HSP72.
Similar articles
-
Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart.Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1892-9. doi: 10.1152/ajpheart.00493.2007. Epub 2007 Jun 22. Am J Physiol Heart Circ Physiol. 2007. PMID: 17586615
-
Role of protein kinase C in geranylgeranylacetone-induced expression of heat-shock protein 72 and cardioprotection in the rat heart.J Mol Cell Cardiol. 2003 Jul;35(7):785-94. doi: 10.1016/s0022-2828(03)00133-0. J Mol Cell Cardiol. 2003. PMID: 12818569
-
Oral administration of geranylgeranylacetone blunts the endothelial dysfunction induced by ischemia and reperfusion in the rat heart.J Cardiovasc Pharmacol. 2005 Jun;45(6):555-62. doi: 10.1097/01.fjc.0000159879.04444.22. J Cardiovasc Pharmacol. 2005. PMID: 15897783
-
The heat shock/stress response in focal cerebral ischemia.Brain Pathol. 1994 Jan;4(1):67-76. doi: 10.1111/j.1750-3639.1994.tb00812.x. Brain Pathol. 1994. PMID: 8025704 Review.
-
Exercise, heat shock proteins, and myocardial protection from I-R injury.Med Sci Sports Exerc. 2001 Mar;33(3):386-92. doi: 10.1097/00005768-200103000-00009. Med Sci Sports Exerc. 2001. PMID: 11252064 Review.
Cited by
-
Heat Shock Proteins: Protection and Potential Biomarkers for Ischemic Injury of Cardiomyocytes After Surgery.Braz J Cardiovasc Surg. 2018 May-Jun;33(3):291-302. doi: 10.21470/1678-9741-2017-0169. Braz J Cardiovasc Surg. 2018. PMID: 30043923 Free PMC article. Review.
-
Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection.Antimicrob Agents Chemother. 2003 Sep;47(9):2914-21. doi: 10.1128/AAC.47.9.2914-2921.2003. Antimicrob Agents Chemother. 2003. PMID: 12936994 Free PMC article.
-
Protective effect of geranylgeranylacetone via enhancement of HSPB8 induction in desmin-related cardiomyopathy.PLoS One. 2009;4(4):e5351. doi: 10.1371/journal.pone.0005351. Epub 2009 Apr 28. PLoS One. 2009. PMID: 19399179 Free PMC article.
-
Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.J Anesth. 2014 Oct;28(5):733-9. doi: 10.1007/s00540-014-1816-8. Epub 2014 Mar 15. J Anesth. 2014. PMID: 24633659
-
Pterostilbene Attenuates Fructose-Induced Myocardial Fibrosis by Inhibiting ROS-Driven Pitx2c/miR-15b Pathway.Oxid Med Cell Longev. 2019 Dec 4;2019:1243215. doi: 10.1155/2019/1243215. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31871537 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources